PEAK6 Investments’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-4,527
Closed -$90.1K 4990
2023
Q3
$71.8K Buy
+4,527
New +$75.3K ﹤0.01% 3532
2023
Q2
Sell
-20,000
Closed -$236K 4873
2023
Q1
$76.8K Buy
+20,000
New +$85.2K ﹤0.01% 3616

Other funds holding IMGN

PEAK6 Investments's IMGN Position: Q4 2023 in Review

PEAK6 Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 4,527 shares — an estimated $90.1K sold.

PEAK6 Investments first reported a position in IMGN in Q1 2023 and held it in 2 quarters. The position peaked at $76.8K in Q1 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • PEAK6 Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • PEAK6 Investments sold 4,527 Immunogen Inc shares in Q4 2023, an estimated $90.1K.
  • PEAK6 Investments first reported a position in Immunogen Inc in Q1 2023 and held it in 2 quarters.
  • PEAK6 Investments's Immunogen Inc position peaked at $76.8K in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on PEAK6 Investments's 13F filing for Q4 2023, filed 13 Feb 2024.